Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Rxo (RXO) Other Gross PP&E Adjustments (2021 - 2025)

Historic Other Gross PP&E Adjustments for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $277.0 million.

  • Rxo's Other Gross PP&E Adjustments rose 5738.64% to $277.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $277.0 million, marking a year-over-year increase of 5738.64%. This contributed to the annual value of $277.0 million for FY2025, which is 5738.64% up from last year.
  • As of Q4 2025, Rxo's Other Gross PP&E Adjustments stood at $277.0 million, which was up 5738.64% from -$254.0 million recorded in Q3 2025.
  • Rxo's Other Gross PP&E Adjustments' 5-year high stood at $277.0 million during Q4 2025, with a 5-year trough of -$256.0 million in Q1 2025.
  • Over the past 5 years, Rxo's median Other Gross PP&E Adjustments value was -$162.0 million (recorded in 2022), while the average stood at -$41.2 million.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first surged by 17225.43% in 2024, then tumbled by 30320.0% in 2025.
  • Quarter analysis of 5 years shows Rxo's Other Gross PP&E Adjustments stood at $202.0 million in 2021, then fell by 0.5% to $201.0 million in 2022, then rose by 10.45% to $222.0 million in 2023, then fell by 20.72% to $176.0 million in 2024, then skyrocketed by 57.39% to $277.0 million in 2025.
  • Its Other Gross PP&E Adjustments stands at $277.0 million for Q4 2025, versus -$254.0 million for Q3 2025 and -$250.0 million for Q2 2025.